PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $147,680 | +23.5% | 104,000 | 0.0% | 0.00% | – |
| Q2 2023 | $119,600 | -40.1% | 104,000 | -44.8% | 0.00% | -100.0% |
| Q1 2023 | $199,810 | +2.1% | 188,500 | +46.4% | 0.00% | 0.0% |
| Q4 2022 | $195,749 | -73.9% | 128,782 | -63.6% | 0.00% | -66.7% |
| Q3 2022 | $750,000 | -0.1% | 353,733 | -36.9% | 0.00% | +50.0% |
| Q2 2022 | $751,000 | -69.8% | 560,445 | -52.5% | 0.00% | -71.4% |
| Q1 2022 | $2,488,000 | +50.4% | 1,178,978 | +164.4% | 0.01% | +75.0% |
| Q4 2021 | $1,654,000 | +115.4% | 445,837 | +189.7% | 0.00% | +100.0% |
| Q3 2021 | $768,000 | -17.9% | 153,920 | +7.3% | 0.00% | 0.0% |
| Q2 2021 | $935,000 | -66.8% | 143,415 | -64.9% | 0.00% | -71.4% |
| Q1 2021 | $2,813,000 | +336.8% | 408,285 | +546.7% | 0.01% | +250.0% |
| Q4 2020 | $644,000 | +341.1% | 63,133 | +51.6% | 0.00% | +100.0% |
| Q3 2020 | $146,000 | -52.6% | 41,633 | -32.6% | 0.00% | -50.0% |
| Q2 2020 | $308,000 | +25.2% | 61,787 | -14.6% | 0.00% | 0.0% |
| Q1 2020 | $246,000 | – | 72,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |